Tag: Observer
Latest article
Brighter : Participated within the 14 Worldwide Convention on Superior Applied sciences and Remedies for...
Brighter AB (publ) announced today that the company's participation in the International Conference on Advanced Technologies and Treatments of Diabetes (ATTD) 2021, which took...
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Honeysuckle Important Oil Market 2021-2027: Business Development, Aggressive Evaluation & Future Prospects
LOS ANGELES, United States: The report is a fine example of a comprehensive and accurate research study on the global Honeysuckle...